migraine

Search with Google Search with Bing
Information
Disease name
migraine
Disease ID
DOID:6364
Description
"A brain disease that is characterized by moderate to severe headaches, nausea, extreme sensitivity to light and sound and intense unilaterial throbbing or pulsing." [url:http\://en.wikipedia.org/wiki/Migraine, url:http\://www.mayoclinic.com/health/migraine-headache/DS00120]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT05112289 Active, not recruiting N/A A Study to Evaluate White Matter Hyperintensities in Migraine August 16, 2021 August 2024
NCT06158230 Active, not recruiting Phase 2 Comparison of Efficacy Between Combination of Amitriptyline-propranolol and Pizotifen for Migraine Prophylaxis. March 19, 2023 January 15, 2024
NCT04100135 Active, not recruiting N/A GORE® CARDIOFORM Septal Occluder Migraine Clinical Study February 5, 2021 August 2026
NCT06004388 Active, not recruiting Phase 3 Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiving CGRP Therapy (ReMMiD-C) July 21, 2023 June 12, 2024
NCT03867201 Active, not recruiting Phase 3 Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine Patients August 26, 2019 June 28, 2024
NCT05090683 Active, not recruiting N/A Evaluation of a Mind-body Based Application for the Treatment of Chronic/Persistent Pain. October 15, 2021 December 15, 2022
NCT05477095 Active, not recruiting Phase 1 A Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-313 in Healthy Participants July 6, 2022 October 2023
NCT05458011 Active, not recruiting Phase 3 A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With Migraine August 23, 2022 July 3, 2024
NCT03511846 Active, not recruiting Phase 1 Pain Biomarker Study March 21, 2018 May 31, 2025
NCT05940870 Active, not recruiting A Prospective Post-marketing Observational Study Assessing the Safety and Efficacy of Nerivio for Migraine Prevention. July 3, 2023 May 1, 2024
NCT05399485 Active, not recruiting Phase 3 Efficacy and Safety Study of Rimegepant for Migraine Prevention in Japanese Subjects (Japan Only) August 9, 2022 November 9, 2024
NCT05217927 Active, not recruiting Phase 4 Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens March 4, 2022 December 8, 2024
NCT05064371 Active, not recruiting Phase 3 Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan September 21, 2021 June 10, 2024
NCT06112587 Active, not recruiting N/A Muscle Function and Strength Training of the Neck and Shoulder in Migraine and Tension-type Headache Patients. A Singel Arm Open Label Trial October 6, 2023 May 15, 2024
NCT04845178 Active, not recruiting Phase 2 Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults March 1, 2021 September 5, 2024
NCT03301441 Active, not recruiting Sensitivity to Acute Cerebral Ischemia in Migrainers February 9, 2018 July 2024
NCT05207865 Active, not recruiting Phase 4 Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention March 15, 2022 July 5, 2024
NCT05854992 Active, not recruiting Treatments of Migraine With Triptans in Individuals With Elevated Cardiovascular Risk and in Pregnant Women July 5, 2022 December 30, 2024
NCT04796766 Active, not recruiting N/A Human Electrophysiological Model to Quantify the CGRP-related Axon Reflex of Trigeminal Afferents February 1, 2021 December 2024
NCT04574713 Active, not recruiting Phase 2 Candesartan for Migraine Prevention: April 26, 2020 October 2024
NCT05616741 Active, not recruiting N/A Home-based Biofeedback for the Prevention of Migraine January 1, 2023 September 1, 2024
NCT03081390 Active, not recruiting N/A Migraine and CVD Risk in Women April 1, 2017 June 30, 2024
NCT00212810 Completed Phase 4 Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache. September 2005 August 2007
NCT00212823 Completed Phase 4 The Effectiveness of Almotriptan Malate (AXERT®) 12.5 Milligrams When Taken at the Onset of Migraine Pain June 2004 February 2005
NCT00216606 Completed Phase 3 The Effectiveness and Safety of Topiramate on Prevention of Chronic Migraine December 2003 July 2005
NCT00216619 Completed Phase 3 The Prolonged Use of Topiramate for Preventing Migraine Headaches November 2003 August 2006
NCT00216736 Completed Phase 4 Oral Dexamethasone for Treatment of Migraine April 2005 July 2007
NCT00228605 Completed Phase 3 Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain March 2005 May 2007
NCT00231595 Completed Phase 3 A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine March 2001 November 2002
NCT00236509 Completed Phase 3 A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine February 2001 September 2002
NCT00236561 Completed Phase 3 A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of Migraine April 2001 December 2002
NCT00237302 Completed Phase 3 A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Preventing Migraine Headaches in Children July 2001 September 2003
NCT00240630 Completed Phase 3 Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks October 2005 June 2006
NCT00246337 Completed Phase 2 A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004) November 2005 May 2006
NCT00250458 Completed Phase 3 Study to Test a Marketed Product in the Treatment of Migraine-associated Nausea March 2006 October 2006
NCT00253175 Completed Phase 3 A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine October 2000 December 2001
NCT00256802 Completed N/A The Diameter of the Middle Cerebral Artery Measured With Magnetic Resonance Angiography June 2004 January 2005
NCT00257010 Completed Phase 3 A 1-year Study in Adolescents to Assess the Long-term Safety of Almotriptan Malate When Treating Their Migraine Headaches December 2005 December 2007
NCT00259649 Completed Phase 4 Prospective Survey of Menstrual Migraine & Prevention With Eletriptan August 2004
NCT00272896 Completed N/A Hemodynamic and Headache-Inducing Effect of Intravenous Vasoactive Intestinal Peptide in Migraineurs October 2004 September 2005
NCT00286078 Completed N/A Treatment for Migraines With an Implantable Device February 2006 November 7, 2018
NCT00297375 Completed Phase 4 A Study Comparing the Effectiveness and Safety of ULTRACET® (Tramadol HCl/Acetaminophen) Versus Placebo for the Treatment of Acute Pain From a Migraine Headache April 2003 August 2003
NCT00300924 Completed Phase 3 A Study of Rizatriptan Co-Administered With Acetaminophen for the Treatment of Acute Migraine March 2006 January 2007
NCT00301665 Completed Phase 2 Efficacy and Safety Study of Dysport® Used for Migraine Prophylaxis February 2003 March 2005
NCT00319137 Completed Phase 2 An Adaptive Design Trial Of GW274150 In The Treatment Of Acute Migraine December 2005
NCT00329355 Completed Phase 3 Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA) May 2006 November 2006
NCT00329771 Completed Research Study to Determine Sensitivity to Gentle Touch and Pressure During an Active Migraine Attack. March 2006 March 2008
NCT00330850 Completed Phase 3 An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine Attack May 2006 December 2006
NCT00335777 Completed Phase 4 A Research Study Examining Migranal and Skin Sensitivity in Subjects With Migraine August 2006 April 2009
NCT00335803 Completed A Research Study To Compare Two Kinds Of Daily Headache March 2006 September 2007
NCT00360282 Completed N/A Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines? August 2006 March 2010
NCT00364806 Completed Phase 4 Prochlorperazine vs Metoclopramide August 2006 March 2007
NCT00374530 Completed N/A Headache Inducing Characteristics and Possible Changes in Cerebral Blood Flow After Administration of PGE2 August 2006
NCT00384774 Completed Phase 2 A Placebo-Controlled Adaptive Treatment Assignment Study of Intravenous COL-144 in the Acute Treatment of Migraine November 2006 June 2007
NCT00386880 Completed Prevalence of Phonophobia and Cutaneous Allodynia in Episodic Migraineurs August 2006 September 2007
NCT00397254 Completed Phase 4 Two Rizatriptan Prescribing Portions for Treatment of Migraine December 2006 January 2008
NCT00399633 Completed N/A Neuropeptides in the Humane Intra- og Extracerebral Circulation. January 2007 April 2007
NCT00432237 Completed Phase 3 Safety and Efficacy Study of MK0974 in the Acute Migraine (0974-016) March 2007 December 2007
NCT00440232 Completed N/A A Research Study To Evaluate If Frovatriptan Is Safe And Effective In Preventing Migraine Headache After Fasting July 2007 September 2009
NCT00440518 Completed Phase 2 A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis February 2007 July 2008
NCT00442936 Completed Phase 3 Study of Telcagepant (MK-0974) in Participants With Moderate to Severe Acute Migraine With or Without Aura (MK-0974-011) February 15, 2007 October 2, 2007
NCT00443209 Completed Phase 3 Telcagepant (MK-0974) Long-Term Safety Study in Adult Participants With Acute Migraine (MK-0974-012) February 21, 2007 January 22, 2009
NCT00443352 Completed Phase 4 A Research Study Examining The Use Of Duloxetine In The Prevention Of Migraine Headache August 2007 November 2012
NCT00449787 Completed Phase 4 Comparing Naproxen to Sumatriptan for Emergency Headache Patients March 2007 July 2009
NCT00457184 Completed Thrombophilia and Migraine, Are They Related? January 2004 June 2007
NCT00471861 Completed Inflammatory Markers in Patients With Active Migraine Headaches May 2007 February 2009
NCT00475514 Completed Phase 3 A Controlled Trial to Investigate the Efficacy and Safety of Frovatriptan to Prevent Menstrual Migraine October 2004 March 2006
NCT00483717 Completed Phase 2 Efficacy and Safety of Intranasal Ketorolac for the Acute Treatment of Migraine July 2007 January 2008
NCT00489476 Completed Phase 2 Staccato Loxapine in Migraine (in Clinic) June 2007 December 2007
NCT00510419 Completed Phase 3 A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack July 2007 December 2007
NCT00516737 Completed Phase 3 Study to Test Rizatriptan in the Early Treatment of Acute Migraine (0462-081) October 3, 2007 April 8, 2008
NCT00521196 Completed N/A Migraine--Investigational Treatment of Migraine With Noninvasive Brain Stimulation. (tDCS- Migraine) July 2007 January 13, 2012
NCT00551980 Completed Phase 3 The Efficacy of a Cognitive and Physical Intervention to Reduce Head and Muscle Pain in a Working Community October 2007 November 2009
NCT00562289 Completed Phase 3 Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence December 2007 December 2016
NCT00567086 Completed Phase 2 Study to Assess the Safety, Tolerance and Efficacy of Tezampanel in Patients With Acute Migraine October 2006 August 2007
NCT00599586 Completed N/A Randomized Controlled Trial of Treating Migraine With Acupuncture November 2007 September 2009
NCT00610727 Completed Phase 1 Staccato Prochlorperazine Single Dose PK Study August 2004 October 2004
NCT00617695 Completed Phase 3 Efficacy of Zolmitriptan (Zomig) in the Treatment of Migraines in Adolescents September 2003 October 2004
NCT00617747 Completed Phase 3 Efficacy and Tolerability of Zolmitriptan Nasal Spray September 2002 June 2003
NCT00632385 Completed Phase 4 Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy January 2003 August 2003
NCT00634985 Completed Phase 4 Safety and Efficacy of Eletriptan for the Treatment of Migraine in Subjects Unsuccessfully Treated With Nonsteroidal Anti-inflammatory Drugs November 2002 December 2003
NCT00637286 Completed Phase 4 ZAP, US. Zomig for Appropriate for Primary Care July 2004 May 2005
NCT00680823 Completed N/A Study of Intramuscular Ropivacaine Injections for Treatment of Pediatric Headache January 2009 June 2016
NCT00682734 Completed Phase 3 Metoclopramide for Migraine: A Dose Finding Study April 2008 March 2010
NCT00690716 Completed Phase 2 The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Mild Headache in People Who Experience Migraines August 2008 June 2009
NCT00712725 Completed Phase 2 MK3207 for Treatment of Acute Migraines (3207-005) July 2008 January 2009
NCT00725140 Completed Standardized sTudy With Almotriptan in eaRly Treatment of Migraine June 2008 July 2009
NCT05780580 Completed Prescription of Triptans in the Grand Est Region, France July 15, 2020 July 30, 2020
NCT00092963 Completed Phase 3 Study to Test an Approved Product in the Early Treatment of Migraine (0462-065) August 17, 2004 January 14, 2005
NCT00095004 Completed Phase 3 Study to Test an Approved Product in the Early Treatment of Migraine (0462-066) October 21, 2004 April 4, 2005
NCT00111709 Completed Phase 3 Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-071) May 27, 2005 February 26, 2006
NCT00111722 Completed Phase 3 Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072) May 27, 2005 February 23, 2006
NCT00122278 Completed Phase 3 Headache in the Emergency Department (ED) - A Multi-Center Research Network to Optimize the ED Treatment of Migraines July 2005 August 2006
NCT00174395 Completed Phase 4 A Trial to Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine March 2005 October 2006
NCT00195741 Completed Phase 3 The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in Adolescents May 2003
NCT00195806 Completed Phase 3 Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatment of Adolescents With Migraine February 2005
NCT00203216 Completed N/A A Clinical Study Examining the Safety and Effectiveness of a New Medication (Keppra®) for the Prevention of Migraine Headaches September 2002 September 2005
NCT00203268 Completed N/A A Study Examining the Use of a Migraine Medicine in the Treatment of Two Migraine Attacks in Patients Who Have Increased Skin Sensitivity December 2003 March 2005
NCT00203294 Completed N/A A Research Study to Examine the Difference Between Local Anesthetics Alone and Local Anesthetics Plus Steroids in the Treatment of Chronic Headache June 2005 June 2006
NCT00203346 Completed Research Study Examining Nerve Block for Migraine June 2005
NCT00208065 Completed Phase 4 Evaluation of Histamine, CGRP and VIP as Markers for Activation of Trigeminal and Parasympathetic Nerve Fibers May 2004 November 2005
NCT00210483 Completed Phase 3 A Study of 3 Dosage Strengths of Almotriptan Malate (AXERT®) in the Treatment of Acute Migraine in Adolescents July 2003 July 2005
NCT00210496 Completed Phase 4 Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine June 2005 June 2007
NCT00210509 Completed Phase 4 A Study of the Effectiveness and Safety of Almotriptan Versus Placebo in the Treatment of Migraine Headache November 2004 June 2005
NCT00210535 Completed Phase 3 A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine Attacks in Children June 2005 November 2006
NCT00210821 Completed Phase 3 Comparing the Safety and Effectiveness of Topiramate With the Safety and Effectiveness of Amitriptyline in Preventing Migraine Headaches February 2004 November 2005
NCT00210860 Completed Phase 3 An Open Label Extension of a Study Comparing Topiramate and Amitriptyline in Migraine Prevention. September 2004 March 2006
NCT00210873 Completed Phase 3 An Open Label Extension of a Study of Topiramate in Chronic Migraine. February 2004 August 2005
NCT00210912 Completed Phase 3 A Study of the Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine Headaches September 2003 April 2005
NCT01542307 Completed Phase 2 Normobaric Oxygen (NBO) Therapy in Acute Migraine July 2012 September 2015
NCT01545466 Completed N/A Non-drug Interventions for Migraines February 2012 October 2012
NCT01613248 Completed Phase 2 A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006) July 1, 2012 December 1, 2012
NCT01637662 Completed N/A Natriuretic Peptide's Headache Inducing Characteristics and Effects on the Cerebral Blood Flow July 2012
NCT01657370 Completed Phase 2 A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007) August 2012 December 2012
NCT01667679 Completed Phase 3 Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without Aura August 2012 June 2014
NCT01687101 Completed N/A STOPAIN in the Treatment of a Single Migraine Attack May 2012 May 2013
NCT01688739 Completed Phase 1 Ascending Single Doses of Erenumab (AMG 334) in Healthy Adults and Migraine Patients March 13, 2012 March 27, 2013
NCT01695317 Completed Phase 4 Effect of Acetyl-L-carnitine in Migraine April 2013 September 2014
NCT01723514 Completed Phase 1 Ascending Multiple-Doses of Erenumab (AMG 334) in Healthy Adults and in Migraine Patients November 14, 2012 July 10, 2014
NCT01741246 Completed Neuroimaging Studies of Chronic Primary Headaches Using Positron Emission Tomography and Magnetic Resonance Imaging September 2011 June 2015
NCT01750723 Completed N/A Acetazolamide's Headache Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow December 2012 April 2013
NCT01756209 Completed Phase 4 Acetaminophen and Ibuprofen With and Without Magnesium and Primary Migraine in Childhood January 2010 February 2012
NCT01772524 Completed Phase 1 Safety, Efficacy and Pharmacokinetics of ALD403 January 2013 February 2014
NCT01775852 Completed N/A Brief Behavioral Intervention for Comorbid Migraine and Depression August 2010 August 2013
NCT01799590 Completed Phase 2 Continuous Treatment Study of Topiramate in Migraine Participants August 2007 November 2009
NCT01820559 Completed Phase 2 Efficacy and Safety of Eslicarbazepine Acetate as Preventive Therapy for Subjects With Migraine April 2009 June 2010
NCT01825941 Completed Phase 4 Diphenhydramine for Acute Migraine April 2013 December 2014
NCT01836874 Completed A Study of Prophylaxis for Migraine Patients With Topiramate in India May 2007 July 2008
NCT01841827 Completed N/A The Headache Inducing Effects of Cilostazol on Migraine Patients April 2013 June 2013
NCT01845051 Completed Is There a Comorbidity Between Migraine and Allergic Rhinitis? November 2012 March 2013
NCT01851148 Completed N/A Clinical Effectiveness of Osteopathic Manipulative Treatment in Chronic Migraine March 2010 March 2012
NCT01854580 Completed Evaluation of an Integrated Care Project March 2013 December 31, 2018
NCT01880671 Completed N/A Evaluation of a New Treatment for Migraine Attacks May 2013
NCT01896167 Completed N/A Migraine With Aura Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow by Hypoxia April 2013 September 2014
NCT01898455 Completed N/A Intranasal Cooling for Cluster Headache and Migraine August 2013 August 2014
NCT01916395 Completed Comparison of Treximet & Imitrex as They Affect the Levels of Inflammatory Markers When the Patient is Actively Having a Migraine Headache December 2009 July 2011
NCT01939314 Completed Phase 3 Sphenopalatine Nerve Block for Headache Tx360 October 2012 December 2013
NCT01952574 Completed Phase 2 Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention August 6, 2013 November 12, 2019
NCT01953341 Completed Phase 1 Single-Ascending Dose Study of AMG 333 in Healthy Subjects and Subjects With Migraines October 2013 November 2014
NCT01970943 Completed N/A Molecular and Functional PET-fMRI Measures of Analgesia in Migraine September 1, 2012 October 30, 2017
NCT01980927 Completed N/A Changes in Intracranial Compliance in Migraine Subjects Following a National Upper Cervical Chiropractic Association Atlas Correction November 2011 November 2014
NCT02035111 Completed Phase 4 A Randomized, Placebo-Controlled, Double-blind Study of Tianshu Capsule in the Treatment of Migraine. March 2014 November 2015
NCT02066558 Completed N/A Carbon Monoxide's Headache Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow February 2014 December 2014
NCT02101892 Completed N/A Prediction of Migraine Prevention Efficacy Based on Individual's Pain Modulation April 2014 February 2016
NCT02108678 Completed N/A One-Day Intervention for Depression and Impairment in Migraine Patients September 2013 September 2017
NCT02127294 Completed N/A Effectiveness and Safety of Transcatheter Patent Foramen Ovale Closure for Migraine January 2013 January 2016
NCT02133209 Completed N/A MRI Outcomes of Mindfulness Meditation for Migraine May 2014 March 2018
NCT02159547 Completed Phase 4 IV Dexketoprofen vs Placebo in Migranie Attack May 2014 August 2014
NCT02219269 Completed A Complex Contraception Registry June 2014 June 2015
NCT02243865 Completed N/A Chordate System Prophylactic Migraine Clinical Investigation October 2014 December 2015
NCT02269501 Completed N/A Exercise in Migraine and Co-existing Tension-type Headache and Neck Pain November 2012 May 23, 2018
NCT02287376 Completed Phase 4 Pharmacokinetics & Safety of Cambia® in Migraine With or Without Aura in 12-17 Year Olds January 2015 February 2016
NCT02315833 Completed N/A The Efficacy of L-cysteine in Prevention of Headache Attacks in Migraine Patients December 17, 2013 September 7, 2020
NCT02322333 Completed Phase 2/Phase 3 MLD10 in the Prevention of Migraine in Adults March 2015 June 2017
NCT02342743 Completed N/A Open-trial on the Prevention of Chronic Migraines With the CEFALY Device February 2, 2015 April 11, 2017
NCT02358681 Completed Phase 3 Intranasal Ketorolac Versus Intravenous Ketorolac for Treatment of Migraine Headaches in Children June 16, 2015 March 31, 2021
NCT02378844 Completed N/A A Randomized, Sham-controlled Study of gammaCore ® (nVNS) for Prevention of Episodic Migraine June 2015 August 29, 2018
NCT02389829 Completed Phase 4 Hydromorphone Versus Prochlorperazine + Diphenhydramine for Acute Migraine March 2015 October 2016
NCT02403687 Completed Prospective Analgesic Compound Efficacy (PACE) Study June 2015 February 2017
NCT02411513 Completed Phase 1 Acute Treatment of Migraine Using the CEFALY Device April 2015
NCT02425696 Completed Registry of Right-to-left Shunt Detection by Contrast-enhanced Transcranial Doppler in Chinese Population June 2015 August 2017
NCT02443519 Completed N/A Bronx MBCT-Migraine July 2015 February 2019
NCT02446275 Completed N/A Efficacy of Manual Therapy in Migraine January 2014 November 2014
NCT02456740 Completed Phase 3 Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention July 17, 2015 June 19, 2017
NCT02468622 Completed Transcriptomic and Biochemical Changes During a Migraine Attack August 2015 June 2016
NCT02472418 Completed Phase 2 Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches June 5, 2015 May 5, 2016
NCT02483585 Completed Phase 3 Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) Compared to Placebo in Migraine Prevention July 20, 2015 March 20, 2017
NCT02485340 Completed N/A The Effect of Sumatriptan and Placebo on Isosorbide-5-mononitrate Induced Headache April 2015 August 2015
NCT02486276 Completed N/A The Effect of Sumatriptan and Placebo on Cilostazol Induced Headache June 2015 June 2016
NCT02518464 Completed Phase 4 Ticagrelor Therapy for RefrACTORy Migraine Study October 2015 October 2017
NCT02542605 Completed Phase 1 To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine Patients November 11, 2015 November 8, 2017
NCT02568644 Completed N/A Ginger Capsules for the Acute Treatment of Migraine Attacks July 2014 October 2014
NCT02570633 Completed N/A Ginger Capsules for the Prophylactic Treatment of Migraine April 2015 November 2016
NCT02580968 Completed N/A Study of Key Electro-acupuncture Technique on Migraine March 2015 December 2017
NCT02590939 Completed N/A Acute Treatment of Migraine With e-TNS February 1, 2016 March 31, 2017
NCT02593097 Completed Phase 3 Metformin for the Prevention of Episodic Migraine (MPEM) February 2016 June 2019
NCT02609945 Completed Phase 1 Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults November 2015 April 2016
NCT02614183 Completed Phase 3 Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study November 30, 2015 August 9, 2018
NCT02614196 Completed Phase 3 Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study December 4, 2015 October 5, 2018
NCT02614287 Completed Phase 3 A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura November 30, 2015 August 14, 2018
NCT02614378 Completed N/A Abortive Effect of an Ear Insufflator on Migraine November 2015 December 2016
NCT02615314 Completed Clinical Aspects of Patients With Benign Paroxysmal Positional Vertigo (BPPV) and Migraine January 2015 July 2015
NCT02616978 Completed Retrospective Study on the Use of CEFALY® Device During Migraine Attacks November 2015 December 2015
NCT02621931 Completed Phase 3 Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine March 22, 2016 April 11, 2017
NCT02629861 Completed Phase 3 Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine March 23, 2016 April 10, 2017
NCT02630459 Completed Phase 2 A Safety and Efficacy Study to Evaluate AMG 334 in Migraine Prevention January 6, 2016 June 5, 2019
NCT02638103 Completed Phase 3 Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of Migraine February 26, 2016 December 8, 2018
NCT02665273 Completed Phase 3 Greater Occipital Nerve Block With Bupivacaine for Acute Migraine July 1, 2015 January 2018
NCT02686034 Completed N/A RCT of Non-Invasive Vagus Nerve Stimulation (nVNS) With gammaCore®, for the Acute Treatment of Migraine Attacks January 2016 March 2017
NCT02695498 Completed N/A Mindfulness and Mechanisms of Pain Processing in Adults With Migraines August 26, 2016 July 17, 2019
NCT02703129 Completed N/A Nutritional Intervention in Migraine January 2010 December 2012
NCT02721849 Completed N/A Yoga for Chronic Headache in Adolescents April 2016 July 2017
NCT02764320 Completed N/A The MOTS (Medication Overuse Treatment Strategy) Trial January 9, 2017 March 31, 2021
NCT02764996 Completed N/A An Exploratory Prospective Trial of Rescue Acupuncture for the Treatment of Acute Migraine December 2015 June 2017
NCT02791893 Completed N/A Vagus Nerve Stimulation: Treatment for Gulf Veterans With Gulf War Illness March 21, 2017 April 15, 2020
NCT02794441 Completed Phase 3 Oral Dexamethasone for the Treatment of Acute Migraine Recurrence in the Pediatric Emergency Department December 2016 June 28, 2017
NCT02824250 Completed N/A Mindfulness and Migraine Research Study March 9, 2017 May 31, 2020
NCT02847494 Completed Phase 4 Corticosteroids for Acute Migraine in the Emergency Department September 1, 2016 September 30, 2017
NCT02901756 Completed A Combination of Coenzyme Q10, Feverfew and Magnesium for Migraine Prophylaxis : a Prospective Observational Study January 2015 December 2015
NCT02905227 Completed Phase 1 A Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation Powder September 2016 December 2016
NCT02959177 Completed Phase 2 A Study of LY2951742 (Galcanezumab) in Japanese Participants With Episodic Migraine November 9, 2016 January 18, 2019
NCT02959190 Completed Phase 3 A Study of LY2951742 (Galcanezumab) in Japanese Participants With Migraine February 7, 2017 August 10, 2019
NCT03004313 Completed N/A Structural and Molecular Neuroplasticity in Migraine January 2011 October 2014
NCT03009162 Completed Phase 1 Study of Oral Lasmiditan in Participants With Normal and Impaired Renal Function April 1, 2017 June 2, 2017
NCT03012334 Completed Phase 1 The Effects of Lasmiditan on Simulated Driving Performance - Healthy Participants January 16, 2017 June 8, 2017
NCT03040479 Completed Phase 1 Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Normal and Impaired Hepatic Function March 14, 2017 July 17, 2017
NCT03076060 Completed N/A Very Low Calories Ketogenic Diet in Migraine. January 1, 2017 October 23, 2017
NCT03076970 Completed Phase 1 Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Participants March 21, 2017 April 13, 2017
NCT03125525 Completed Clinical Experience With Transcutaneous Supraorbital Nerve Stimulation in Refractory Migraine January 1, 2016 June 30, 2016
NCT03132233 Completed N/A Energy for the Brain May 8, 2017 January 31, 2020
NCT03156920 Completed N/A Pretreatment With Sumatriptan on Cilostazol Induced Headache in Healthy Volunteers May 23, 2017 October 18, 2017
NCT03166046 Completed N/A Migraine Prevention Using ActiPatch June 1, 2017 April 30, 2018
NCT03167060 Completed N/A BrainCool-Migraine Intranasal Cooling Trial May 8, 2017 February 6, 2019
NCT03175900 Completed Phase 4 Effectiveness and Neural Mechanism of Naoan Dripping Pills for Migraine June 17, 2017 August 4, 2018
NCT03177616 Completed N/A Integrative Migraine Pain Alleviation Through Chiropractic Therapy June 7, 2017 November 4, 2022
NCT03183791 Completed N/A RELAXaHEAD for Headache Patients (Phase I) November 1, 2017 May 25, 2019
NCT03217968 Completed N/A Abortive Treatment of Migraine With the Cefaly® Abortive Program Device August 10, 2017 January 10, 2018
NCT03269435 Completed Phase 4 Greater Occipital Nerve Block Versus Metoclopramide November 1, 2017 March 21, 2020
NCT03275922 Completed Phase 3 Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE November 27, 2017 September 28, 2020
NCT03282227 Completed Phase 3 A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine November 7, 2017 May 17, 2019
NCT03282838 Completed Phase 1 Study on the Pharmacokinetics (PK) of DFN-15 vs Comparator and Food-effect on DFN-15 PK in Healthy Adult Subjects June 9, 2017 January 12, 2018
NCT03303079 Completed Phase 2/Phase 3 Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Chronic Migraine December 19, 2017 November 30, 2019
NCT03303092 Completed Phase 2/Phase 3 Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Episodic Migraine December 19, 2017 November 22, 2019
NCT03303105 Completed Phase 3 Long-term Safety and Tolerability of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine December 7, 2017 June 16, 2020
NCT03335163 Completed Phase 1 The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users March 15, 2018 April 22, 2021
NCT03381261 Completed Phase 4 (Botox) Mechanisms of Action in Altering the Molecular Environment in Which Pain Fibers Exist December 1, 2017 December 1, 2023
NCT03381924 Completed N/A Educational Intervention in Patients With Migraine August 1, 2013 May 30, 2016
NCT03398668 Completed N/A Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine February 22, 2018 December 30, 2018
NCT03422796 Completed N/A The Effect of Sumatriptan and Placebo Injection on Cilostazol Induced Headache November 1, 2017 September 1, 2018
NCT03459495 Completed N/A Therapeutic Ultrasound in the Treatment of Migraine March 10, 2018 December 10, 2018
NCT03465904 Completed N/A A Phase III Trial of e-TNS for the Acute Treatment of Migraine April 10, 2018 January 11, 2019
NCT03488563 Completed Phase 2 Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine March 30, 2018 July 16, 2019
NCT03499119 Completed Phase 1 AMG 334 20160172 Pediatric Migraine PK Study. May 4, 2018 November 23, 2021
NCT03520777 Completed N/A A Pilot Study of Creative Arts Interventions for Neurology Inpatients September 19, 2017 June 30, 2018
NCT03536936 Completed Oxygenation and Perfusion in Patients With Acute Migraine Attacks January 1, 2010 April 30, 2018
NCT03542357 Completed N/A The Effect of Sumatriptan and Placebo on CGRP Induced Headache February 15, 2018 September 1, 2018
NCT03555214 Completed N/A Efficacy of Manual Therapy for the Treatment of Migraine. June 30, 2018 December 3, 2019
NCT03556722 Completed N/A Transcranial Magnetic Stimulation in Episodic Migraine (Magnet-EM) April 15, 2019 April 1, 2022
NCT03559088 Completed N/A A Study of the Effect of a Disease-Specific Migraine Smart Phone Application (App) on Participant Care June 11, 2018 April 26, 2019
NCT03559257 Completed Phase 3 A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine July 31, 2018 September 19, 2019
NCT03597529 Completed Phase 2 CHOCOlate MeLatonin for AdolescenT MigrainE September 25, 2017 December 1, 2019
NCT03666663 Completed Phase 4 Sphenopalatine Ganglion Blocks RCT February 1, 2019 July 8, 2021
NCT03670810 Completed Phase 3 A Study of Lasmiditan (LY573144) Over Four Migraine Attacks June 24, 2019 July 8, 2021
NCT03701477 Completed N/A Trans-diagnostic Cognitive-behavioral Therapy for Treatment of Migraine October 1, 2018 September 30, 2019
NCT03706794 Completed N/A Clinical Decision Support for Patient Migraine Management June 5, 2019 March 13, 2022
NCT03708744 Completed Phase 1 A Study of M207 With Intranasal Zolmitriptan in Healthy Volunteers November 1, 2018 November 20, 2018
NCT03712917 Completed N/A Comparison of Therapeutic Effects of Greater Occipital Nerve Block, Topiramate, and Flunarizine on Episodic Migraine March 1, 2019 March 31, 2019
NCT03732638 Completed Phase 2/Phase 3 Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults November 14, 2018 February 2, 2021
NCT03742024 Completed Study of Pediatric Migraine: The Pediatric Migraine Registry December 5, 2018 February 8, 2021
NCT03766412 Completed High School Start Time and Teen Migraine Frequency October 1, 2018 October 15, 2018
NCT03768830 Completed N/A Impact of Exercise on "Invisible" Symptoms and Quality of Life in Multiple Sclerosis Individuals October 1, 2018 February 5, 2019
NCT03773562 Completed Phase 4 Imaging the Migraine Brain Pre- and Post-Erenumab March 25, 2019 June 30, 2022
NCT03799211 Completed N/A Adherence to and Beliefs on Recommendations for Behavioral Treatment for Migraine June 4, 2018 January 1, 2019
NCT03812224 Completed Phase 3 A Controlled Trial of Erenumab in Migraine Prevention April 12, 2019 November 25, 2020
NCT03828539 Completed Phase 4 Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine February 22, 2019 July 29, 2020
NCT03831659 Completed Migraine and Infertility March 13, 2019 March 26, 2020
NCT03836664 Completed Phase 2 A Randomized Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine February 27, 2017 April 14, 2018
NCT03847753 Completed Exploring the Comorbidity Between Mental Disorders and General Medical Conditions January 1, 2000 January 31, 2020
NCT03872050 Completed Deep Phenotyping of Rosacea and Migraine September 14, 2018 October 29, 2019
NCT03872453 Completed Phase 2/Phase 3 Acute Treatment Trial in Adult Subjects With Migraines March 25, 2019 November 11, 2019
NCT03874832 Completed Phase 1 A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects September 11, 2018 November 7, 2018
NCT03877718 Completed Phase 2 A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain February 1, 2019 August 27, 2019
NCT03896009 Completed Phase 3 Maximizing Outcomes in Treating Acute Migraine March 4, 2019 December 10, 2019
NCT03901482 Completed Phase 3 A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine June 24, 2019 August 13, 2020
NCT03902496 Completed N/A Optical Treatment of Migraines Using the Avulux™ Optical Filter in the Form of Spectacle Lenses. March 18, 2019 May 17, 2019
NCT03962738 Completed Phase 2 A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With Migraine May 31, 2019 June 8, 2020
NCT03978403 Completed Phase 1 A Four-way Crossover Study of 3 Formulations of M207 With Intranasal Zolmitriptan in Healthy Volunteers May 29, 2019 June 28, 2019
NCT03988088 Completed Phase 1 A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine July 22, 2019 February 24, 2020
NCT03999060 Completed N/A Trigeminal Brainstem Mapping June 28, 2019 September 27, 2019
NCT04012047 Completed N/A Headache Inducing Effect of Levcromakalim in Migraine With Aura Patients July 9, 2019 December 10, 2019
NCT04012593 Completed Diary-based Study on the Course of Hormone-withdrawal Migraines January 2017 August 31, 2019
NCT04017741 Completed Phase 4 A Study Investigating the Efficacy of GON Blocks. February 14, 2018 January 23, 2020
NCT04019496 Completed Neurophysiology of Prophylactic Treatment in Migraine January 29, 2019 May 2, 2021
NCT04041284 Completed Phase 4 A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive Disorder September 13, 2019 August 31, 2022
NCT04068051 Completed Phase 3 Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT) July 6, 2019 September 22, 2020
NCT04077658 Completed N/A Heartmath Migraine Study June 16, 2019 January 16, 2020
NCT04084314 Completed Phase 4 Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study September 30, 2019 March 13, 2023
NCT04090333 Completed Endocrinological Profile in Patients With Medication-overuse Headache Before and After Withdrawal Therapy August 1, 2019 October 1, 2020
NCT04112823 Completed Phase 4 Dexamethasone for Migraine - Dose Comparison December 22, 2019 December 31, 2022
NCT04138316 Completed CandeSpartan Study. Candesartan Spanish Response-prediction and Tolerability Study January 2, 2020 December 16, 2022
NCT04152083 Completed Phase 3 A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine November 7, 2019 July 8, 2020
NCT04163185 Completed Phase 3 Initiating Early Control of Migraine Pain and Associated Symptoms October 8, 2019 March 23, 2020
NCT04171362 Completed N/A The Effect of Connective Tissue Massage in Patients With Migraine March 28, 2019 December 20, 2019
NCT04179474 Completed Phase 1 Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine September 26, 2019 December 23, 2019
NCT04185714 Completed N/A THE EFFECTS OF KINESIO®TAPING IN PATIENTS WITH MIGRAINE January 1, 2020 September 30, 2020
NCT04197349 Completed Phase 1 Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and Woman September 24, 2019 August 19, 2020
NCT04252521 Completed N/A Intravenous Metoclopramide Versus Dexketoprofen Trometamol Versus Metoclopramide+ Dexketoprofen Trometamol in Migraine July 3, 2019 January 3, 2020
NCT04252742 Completed Phase 4 Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine September 15, 2020 October 26, 2023
NCT04260035 Completed N/A The Effects of a Long-lasting Infusion of Vasoactive Intestinal Peptide (VIP) in Episodic Migraine Patients May 19, 2020 September 15, 2020
NCT04265755 Completed Phase 4 Biomarker and Genetic Predictors of Erenumab Treatment Response October 26, 2020 January 18, 2023
NCT04281030 Completed N/A Improving Health Outcomes of Migraine Patients Who Present to the Emergency Department June 30, 2019 March 30, 2022
NCT04294147 Completed Phase 4 A Study of Gastrointestinal Emptying Time in Adult Participants With Migraine Before and After Start of a mAb CGRP Antagonist October 6, 2020 March 5, 2021
NCT04299958 Completed Observational Prospective Study on the Presence of Typical Migraine Features in Nummular Headache Patients: The Numamig Study April 1, 2020 April 25, 2023
NCT04341298 Completed N/A Use of the Avulux® Lenses as an Aid in Reducing the Impact of Migraine Headaches April 6, 2020 August 26, 2020
NCT04355117 Completed Phase 3 A Safety Evaluation Trial of TEV-48125 Self-administered in Migraine Patients June 17, 2020 November 11, 2020
NCT04360044 Completed Phase 2 Efficacy of Inhaled Cannabis for Acute Migraine Treatment November 20, 2020 February 23, 2023
NCT04401137 Completed Phase 1 The Evaluation of Pharmacokinetic/Pharmacodynamic Characteristics and Safety of QDX in Healthy Korean Male Subjects July 1, 2020 October 6, 2020
NCT04406649 Completed Phase 3 A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine September 14, 2020 January 16, 2023
NCT04413110 Completed PSG and Neuroendocrine Hormones in Subjective Cognitive Impaired Patients With Transformed Migraine April 1, 2019 April 1, 2020
NCT04418765 Completed Phase 3 A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments June 1, 2020 September 15, 2022
NCT04437199 Completed Phase 2 Tricaprilin Phase 2 Pilot Study in Migraine December 17, 2020 February 7, 2022
NCT04458857 Completed Phase 3 A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age July 15, 2020 March 13, 2024
NCT04461795 Completed Phase 4 Efficacy of AJOVY (Fremanezumab-vfrm) on Interictal Migraine Related Burden December 1, 2020 January 10, 2022
NCT04463875 Completed Magnesium, Vitamin B2, Feverfew, Andrographis Paniculata and Coenzyme Q10 for Episodic Migraine Prophylaxis April 1, 2018 May 31, 2020
NCT04465357 Completed Phase 4 Efficacy of Erenumab on Functional Impact of Migraine October 22, 2020 June 3, 2022
NCT04473976 Completed Plasma Levels of CGRP and Expression of Specific microRNAs in Blood Cells of Episodic and Chronic Migraine Subjects December 15, 2017 June 15, 2019
NCT04492020 Completed Phase 3 Study to Evaluate Oral Ubrogepant in the Acute Treatment of Migraine During the Prodrome in Adult Participants August 21, 2020 April 19, 2022
NCT04498910 Completed Phase 2 A Study of LY3451838 in Participants With Migraine November 16, 2020 November 9, 2022
NCT04509141 Completed N/A Acupuncture as Migraine Prophylaxis in Reducing Frequency, Duration and Intensity of Migraine With Minimum Acupoint, Seen up to Eight Weeks From Baseline July 5, 2019 August 30, 2019
NCT04523311 Completed N/A An Evaluation of Brief Online Hypnosis for Migraine and Tension-type Headaches October 27, 2020 February 24, 2021
NCT04537429 Completed Phase 1 A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab August 4, 2020 August 21, 2023
NCT04571060 Completed Phase 3 Randomized Trial in Adult Participants With Acute Migraines October 27, 2020 October 22, 2021
NCT04572789 Completed N/A Omega-3 Fatty Acid in the Prevention of Migraine December 3, 2020 March 31, 2022
NCT04578782 Completed Phase 2 Efficacy of OnabotulinumtoxinA in Migraine March 13, 2018 May 31, 2020
NCT04659226 Completed N/A MicroRNA Profile and Erenumab Treatment July 1, 2021 April 30, 2023
NCT04660864 Completed N/A Nasal Cavity Cooling for the Symptomatic Relief of Migraine Headache - a Pilot Study March 3, 2021 December 23, 2021
NCT04696510 Completed Physiopathology, Diagnosis and Therapy of Primary Cephalalgia and Adaptive Disorders August 31, 2018 December 15, 2020
NCT04729699 Completed N/A Changes and Associations Between Cervical Range of Motion, Pain, TMJ Range of Motion and Quality of Life in Migraineurs Applying Physical Therapy July 13, 2020 August 24, 2020
NCT04750967 Completed N/A Amitriptyline vs GON and SON Blocks in Migraine April 3, 2021 July 15, 2023
NCT04759040 Completed N/A Improvement of Migraine Severity and Frequency With Migraineguard ™ April 1, 2020 November 25, 2020
NCT04772742 Completed Phase 3 Eptinezumab in Adults With Migraine and Medication Overuse Headache February 17, 2021 September 30, 2022
NCT04804995 Completed Investigating the Frequency and Phenotype of Headaches Associated With Fasting During the Month of Ramadan. March 16, 2021 June 30, 2021
NCT04816357 Completed Identification of Endometriosis and Migraine Criteria in Women With the Comorbidity of Both Conditions in Comparison With Women Who Only Suffer From Endometriosis - A Pilot Study March 25, 2021 November 4, 2021
NCT04818515 Completed Phase 1 Study To Assess Adverse Events and Drug to Drug Interaction of Oral Tablet Atogepant and Ubrogepant in Adult Participants With a History of Migraine March 17, 2021 June 18, 2021
NCT04825678 Completed Phase 4 A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine June 11, 2021 September 28, 2023
NCT04828707 Completed N/A Assessment of Safety and Efficacy of Nerivio for the Migraine Prevention April 13, 2021 October 10, 2022
NCT04841083 Completed N/A Narrow Band Green Light and Migraine December 15, 2020 December 5, 2022
NCT04845152 Completed Migraine in Electrohypersensitive Patients April 30, 2021 January 30, 2022
NCT04912752 Completed N/A Copy Number Variation in CHRNA7 Gene in Migraine and Gene Expression April 5, 2020 January 2, 2021
NCT04940390 Completed Phase 3 A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine June 30, 2021 October 26, 2022
NCT04949204 Completed Context-awareness, Physiological Monitoring, and Machine Learning in Migraine and Cluster Headache July 1, 2020 July 31, 2021
NCT04960657 Completed N/A The Hemodynamic Effects of PACAP38 After Glibenclamide Administration in Healthy Volunteers October 20, 2020 March 19, 2021
NCT04969497 Completed Phase 1 Study of PK, Safety, and Tolerability of 2 Lots of M207 & Intranasal Zolmitriptan in Healthy Volunteers June 24, 2021 September 2, 2021
NCT04983186 Completed N/A mBrain-21 : a Three-month Study on Context-awareness, Physiological Monitoring, and Machine Learning in Migraine and Cluster Headache July 19, 2021 September 7, 2023
NCT04992494 Completed Phase 2 Treatment for Migraine and Mood (Team-M) November 11, 2021 June 13, 2022
NCT04992897 Completed Real-world Data Analysis of REN Treatment in Migraine Patients June 15, 2021 August 7, 2021
NCT05003362 Completed N/A ACT for High Frequency Migraine; A Virtual Mindfulness Intervention October 25, 2020 November 23, 2021
NCT05046522 Completed Phase 3 A Study Evaluating the Effectiveness of PEA Compared to Placebo for Reducing Pain Severity and Duration of Migraines. September 1, 2021 March 9, 2023
NCT05087420 Completed Migraine in Poland - a Web-based Cross-sectional Survey September 1, 2021 April 30, 2022
NCT05127486 Completed Phase 4 A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine December 6, 2021 May 23, 2023
NCT05133323 Completed Phase 2 A Study With Lu AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments November 11, 2021 March 16, 2023
NCT05162664 Completed N/A Presence of Signs of Central Sensitization in Episodic and Chronic Migraine October 15, 2021 October 1, 2022
NCT05177406 Completed Healthcare Costs and Resource Utilization in Aimovig Migraine Patients: a Retrospective Study Using United States Claims Data August 31, 2020 December 31, 2020
NCT05199064 Completed Efficacy of Greater Occipital Nerve Radiofrequency for Refractory Migraine Treatment September 15, 2020 October 15, 2021
NCT05278325 Completed N/A Improved Treatment Course for Patients With Migraine and Tension-type Headache May 1, 2020 October 5, 2021
NCT05282134 Completed N/A Comparison of Wet Cupping and Acupuncture in Migraine January 1, 2022 December 30, 2023
NCT05285852 Completed N/A Effects Of Dry Needling On Sternocleidomastoid Muscle For Pain And Disability In Migraine March 1, 2021 May 15, 2022
NCT05292599 Completed N/A Effect of a Home-based Versus Supervised Exercise Program in Patients With Migraine June 13, 2022 June 20, 2023
NCT05301920 Completed N/A The Evaluation of the Transcutaneous Electrical Stimulation Medical Device's Safety and Effectiveness in Treating the Patients With Migraine October 8, 2021 January 28, 2022
NCT05304910 Completed Phase 1 A Study Investigating the Movement of Lu AG09222 Into, Through, and Out of the Body of Healthy Caucasian, Chinese, and Japanese Participants March 18, 2022 October 30, 2022
NCT05337254 Completed Phase 1 A Study of the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects March 5, 2021 June 4, 2021
NCT05351918 Completed Comparison of Two Different Migraine Acupuncture Treatment February 1, 2022 April 15, 2022
NCT05372796 Completed N/A The Effects of Transcutaneous Occipital Nerve Stimulation and Instrument-Assisted Soft Tissue Mobilization on Patients With Chronic Migraine September 1, 2021 February 26, 2022
NCT05375097 Completed Real-world Impact of Erenumab on Sick-leaves, Health Care Resource Use and Comorbidities. July 3, 2020 May 14, 2021
NCT05377437 Completed N/A Natural Language Processing for Headache Medicine August 28, 2020 December 31, 2023
NCT05399459 Completed Phase 3 Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only) August 9, 2022 January 19, 2024
NCT05442008 Completed Predictive Role of MIDAS Reduction at 3 Months for Erenumab Treatment December 1, 2018 January 1, 2021
NCT05464069 Completed Safety of Nerivio in Pregnant Women With Migraine August 1, 2022 December 7, 2022
NCT05466682 Completed N/A RELAXaHEAD for Headache Patients (Phase II) June 9, 2022 June 19, 2023
NCT05525611 Completed N/A Cabergoline as a Preventive Treatment for Chronic Migraine September 5, 2022 August 8, 2023
NCT05556564 Completed The Impact of Migraine on Canadians' Productivity: A Real-World Pharmacy-Based Study October 31, 2022 March 6, 2023
NCT05568004 Completed N/A The Effect of Exercise on Migraine Attacks in Chronic Migraine November 28, 2022 May 10, 2024
NCT05635604 Completed N/A Migraine Induction Properties of PACAP-38 After Eptinezumab in Migraine Without Aura Patients. March 1, 2023 August 4, 2023
NCT05654298 Completed N/A Influence of Ubrogepant and Sumatriptan on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin March 15, 2022 March 15, 2023
NCT05760638 Completed Real-World Evidence (RWE) Data Analysis of 1-year Consecutive Use of Remote Electrical Neuromodulation (REN) March 1, 2023 April 2, 2023
NCT05769322 Completed Real World Data Analysis: Impact of High-Frequency REN Treatments as Migraine Preventive Therapy in Adolescence April 1, 2023 May 1, 2023
NCT00018811 Completed N/A Psychological Assessment and Treatment of Chronic Benign Headache April 1999 March 2003
NCT05804812 Completed N/A The Effect of Laughter Therapy in Women April 6, 2023 June 28, 2023
NCT05842642 Completed N/A Effects of Adding an Oculomotor Therapy Treatment in Patients With Migraine April 3, 2023 September 15, 2023
NCT05843760 Completed Headache in Undergraduate Students and Biopsychosocial Status May 4, 2023 June 12, 2023
NCT05853900 Completed Phase 3 Study of Two Digital Therapeutics for the Prevention of Episodic Migraine March 28, 2023 May 28, 2024
NCT05933590 Completed Cervical Repositioning Error in Chronic Migraine July 1, 2023 January 6, 2024
NCT05967442 Completed Phase 3 Magnesium Versus Prochlorperazine Versus Metoclopramide for Migraines August 23, 2019 April 6, 2023
NCT05979285 Completed N/A MEDUSA Study - Migraine: Evaluation of Diagnosis, Utilisation of Services and Application October 15, 2020 December 20, 2021
NCT06079801 Completed N/A Bilateral DLPC tDCS in Drug-resistant Migraine October 1, 2021 August 31, 2023
NCT06138756 Completed Acute Treatment of Migraine in Pre-Adolescents: Real-World Analysis of Remote Electrical Neuromodulation (REN) October 1, 2023 October 20, 2023
NCT06155669 Completed N/A The Use of Virtual Reality Applications in Tension-Type Headaches December 15, 2023 January 31, 2024
NCT06180070 Completed Phase 1 Bioequivalence Study to Compare Ibuprofen/ Paracetamol Tablets (200mg Ibuprofen/ 500mg Paracetamol) Versus Nuromol® Tablets (200mg Ibuprofen/ 500mg Paracetamol) August 29, 2023 October 16, 2023
NCT06192173 Completed Patent Foramen Ovale Closure in Migraine September 5, 2022 May 20, 2023
NCT06231615 Completed N/A Efficacy of Fascia Exercises in Migraine Patients October 10, 2022 September 10, 2023
NCT06243874 Completed N/A Comparison of Occipital Nerve and Sphenopalatine Ganglion Blockade September 1, 2023 January 1, 2024
NCT06304675 Completed Manageable Environmental Factors in Migraine September 30, 2023 March 4, 2024
NCT06334796 Completed Early Phase 1 Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology October 1, 2023 January 1, 2024
NCT00742209 Completed Phase 2 Prevention Study in Adult Patients Suffering From Migraine Headaches August 2008 June 2010
NCT00752466 Completed Phase 1 A Drug Interaction Study of the Pharmacokinetics of Topiramate and FLUNARIZINE When Given Together or Separately March 2003 March 2004
NCT00753311 Completed Phase 4 Rizatriptan in Acute Treatment of Migraine in Patients With Unilateral Trigeminal-autonomic Symptoms. July 2009 October 2011
NCT00754611 Completed The Evolution and Management of Migraine Recurrence Beyond 24 Hours December 2008 December 2010
NCT00758836 Completed Phase 2 A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046) December 3, 2008 August 24, 2009
NCT00781456 Completed Phase 2 A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches January 2009 August 2011
NCT00799045 Completed Phase 4 Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal Defects October 2008 December 2016
NCT00812006 Completed Phase 3 A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis March 24, 2009 October 22, 2009
NCT00812214 Completed Phase 4 Treatment of Insomnia in Migraineurs April 2007 September 2008
NCT00821483 Completed Phase 3 A Double Blind Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Frovatriptan in the Acute Treatment of Migraine November 2006 February 2008
NCT00826475 Completed N/A Randomized Trial to Evaluate the Effectiveness of a Mindfulness Based Intervention (MBSR) for Patients Suffering From Migraine January 2009 July 2010
NCT00846495 Completed Phase 4 Pilot Study to Compare Frovatriptan vs. Topiramate for Prevention of Migraine August 2009 January 2011
NCT00849511 Completed Phase 2 Melatonin for Migraine Prevention February 2009 October 2009
NCT00890357 Completed Identifying Factors Underlying the Discontinuation of Triptans August 2009 June 2012
NCT00892203 Completed Phase 2 Efficacy and Safety of BGG492 in the Treatment of Migraine April 2009 August 2010
NCT00893737 Completed Phase 4 "Completeness of Response" Following Treatment With Treximet™ for Migraine June 2009 January 2010
NCT00901862 Completed Phase 1 Magnetic Therapy in Migraine Prophylaxis March 2007 April 2008
NCT00904150 Completed Study of the Molecular Genetics of Menstrual Migraine November 2007 August 2013
NCT00904527 Completed N/A Interest of Relaxation From Patients With Pain Due to Migraine June 2006 April 2009
NCT00965887 Completed Phase 1 Bioequivalence of Two Tablet Forms of MK0974 (0974-045) March 2008 May 2008
NCT00966030 Completed Phase 1 Bioequivalence of the Tablet and Liquid-Filled Capsule Forms of MK0974 (0974-042) March 2008 May 2008
NCT01016678 Completed Phase 2/Phase 3 Treximet Early Intervention Adolescent Migraine March 2010 July 2014
NCT01016834 Completed Phase 4 Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine November 2009 April 2010
NCT01035983 Completed Phase 3 Safety and Tolerability of Frovatriptan to Prevention of Menstrually Associated Migraine (MAM) Headaches December 2003 June 2005
NCT01057160 Completed Phase 4 Rizatriptan 10 MG RPD in the Treatment of Acute Migraine May 2008 June 2010
NCT01060111 Completed Phase 4 An Efficacy and Tolerability Study of Topiramate in Participants With Migraine July 2006 July 2008
NCT01071317 Completed Phase 4 Trial of Comprehensive Migraine Intervention February 2010 January 2012
NCT01073787 Completed Phase 1/Phase 2 Intravenous Fluid for Pediatric Migraine in the Emergency Department July 2010 November 2012
NCT01080287 Completed The Identification and Characterization of Autonomic Dysfunction in Migraineurs With and Without Auras September 2009 September 2011
NCT01081795 Completed Phase 2 A Dose-Finding Study of Topiramate (JNS019) in Participants With Migraine April 2007 January 2009
NCT01085123 Completed Phase 1 Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male Volunteers May 2010 October 2010
NCT01125774 Completed Phase 2/Phase 3 Telcagepant for Prevention of Menstrually Related Migraine in Female Participants With Episodic Migraine (MK-0974-065) June 1, 2010 April 8, 2011
NCT01138150 Completed Phase 4 Ictal and Interictal Inflammatory Markers in Migraine September 2009 June 2013
NCT01152632 Completed N/A Acupuncture for Migraine: a Functional Magnetic Resonance Imaging (fMRI) Study January 2010 December 2013
NCT01161017 Completed N/A Mechanism-based Choice of Therapy for Pain: Can Successful Prevention of Migraine be Coupled to a Psychophysical Pain Modulation Profile? July 2008 May 2014
NCT01161654 Completed N/A Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fed Conditions August 2007 September 2007
NCT01161667 Completed N/A Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fasted Conditions September 2007 September 2007
NCT01170793 Completed N/A Medicine Abuse Headache August 2010 June 2012
NCT01197196 Completed N/A Behavioral Weight Loss as a Treatment for Migraine in Obese Women June 2012 December 2017
NCT01209741 Completed Phase 1 Bioavailability of Variably Aged MK-0974 Tablets (MK-0974-038)(COMPLETED) October 2007 November 2007
NCT01211795 Completed Phase 3 Topical Intra-Oral Ketoprofen for Migraine Prevention October 2009 June 2011
NCT01225263 Completed Phase 2 Statin/Vitamin D & Migraine Study September 2010 January 2015
NCT01265797 Completed N/A Cranial Electrotherapy Stimulation in the Treatment of Migraine Headaches December 2011 July 2013
NCT01287052 Completed N/A Nitrous Oxide for Acute Migraine Pain in the Emergency Room (ED) June 2011 January 2015
NCT01300546 Completed Phase 4 Treximet Trademark (TM) in the Prevention and Modification of Disease Progression in Migraine December 2010 April 2012
NCT01315847 Completed Phase 1 Positron Emission Tomography (PET) Study of Brain Calcitonin Gene-Related Peptide (CGRP) Receptor Occupancy After Telcagepant Administration (MK-0974-067) January 14, 2010 July 26, 2011
NCT01332864 Completed Phase 4 Effect of Osteopathic Manipulative Treatment for Patients With Chronic Headache March 2011 December 2012
NCT01357031 Completed Phase 3 Study With Amitriptylin to Evaluate the Efficacy of Melatonin in Treatment of Migraine May 2010 December 2012
NCT01391091 Completed Phase 3 Effect of Catheter Ablation on Clinical Course of Migraine in AF Patients With or Without Previous History of Migraine December 2010 April 2014
NCT01407861 Completed N/A Aerobic Endurance Training vs. Relaxation Training in Patients With Migraine July 2011 November 2014
NCT01430442 Completed Phase 2 Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine October 2011 May 2012
NCT01445067 Completed Phase 1 Study to Evaluate the PK of BMS-927711 in Patient With Migraine During Acute Migraine and Non-migraine Condition November 2011 September 2012
NCT01450995 Completed Phase 4 Migraine Treatment Satisfaction With Treximet Versus Concomitant 2 Aleve and Imitrex December 2009 May 2011
NCT01470352 Completed N/A Multiparametric MRI Study of Endogenous Analgesia and Prediction the Efficacy of Migraine Pharmacological Prevention November 16, 2011 November 6, 2017
NCT01501045 Completed N/A Effect of Transmagnetic Stimulation on Conditioned Pain Modulation (CPM) January 2011 November 6, 2017
NCT01507610 Completed Phase 1 Bioavailability Study to Compare OPTINOSE SUMATRIPTAN With IMITREX® in Healthy Subjects January 2012 February 2012
NCT01513291 Completed Phase 2 A Study of the Safety and Efficacy of MK-6096 for Migraine Prophylaxis in Participants With Episodic Migraine (MK-6096-020) February 6, 2012 October 3, 2012
NCT01532830 Completed N/A Non-Invasive Neurostimulation For the Relief of Symptoms Associated With Migraine February 2012 July 25, 2012
NCT05016661 Enrolling by invitation Phase 2 Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine Prevention October 19, 2021 September 4, 2025
NCT06127888 Enrolling by invitation Impementation of the Exercise Recommendations for the Treatment of Primary Headaches: A Qualitative Approach to the Headache Units in Catalonia March 20, 2024 June 20, 2024
NCT06212661 Enrolling by invitation Migraine Medication Effects on Urinary Symptoms April 5, 2024 May 2026
NCT00600717 Enrolling by invitation Clinical Applications of High-Frequency Oscillations November 1, 2000 August 1, 2026
NCT04196933 Enrolling by invitation N/A Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma September 5, 2019 December 31, 2023
NCT05127954 Enrolling by invitation Phase 3 Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17) January 14, 2022 May 5, 2027
NCT02670161 Enrolling by invitation Phase 4 Quality Improvement and Practice Based Research in Neurology Using the EMR May 2016 December 2026
NCT05755945 Enrolling by invitation N/A A Study of Wearable Devices to Predict Migraines February 24, 2023 June 2025
NCT05759845 Enrolling by invitation Phase 4 Topiramate, Amitriptyline Monotherapy and Combination Therapy in Migraine Prophylaxis August 22, 2022 May 31, 2023
NCT03934086 No longer available An Open-label, Intermediate Size, Expanded Access Study of BHV-3000 in the Acute Treatment of Migraine
NCT03539393 No longer available Expanded Access Program for Patients With Migraine
NCT05804396 Not yet recruiting N/A Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for Preventive Treatment of Migraine July 2024 December 2024
NCT06439628 Not yet recruiting ARISE-A Chinese Real-world Study of Rimegepant for the Acute Treatment of Migraine August 2024 March 2027
NCT04373330 Not yet recruiting N/A Healthy Living Partnerships for Veterans With Migraine June 2024 December 2024
NCT06149000 Not yet recruiting N/A Migraine Headache Mitigation Utilizing Avulux December 13, 2023 June 20, 2024
NCT06162819 Not yet recruiting N/A Efficacy of Flunarizine Vs Amitriptyline in Prophylaxis of Migraine Prophylaxis January 1, 2024 September 30, 2024
NCT02725554 Not yet recruiting Phase 3 Study of Wireless Nerve Stimulation in the Treatment of Chronic Migraine December 2023 December 2026
NCT06304948 Not yet recruiting The Link Between Human Cytomegalovirus Gene Expression and Glutamate Level in Migraine;Relation to Vitamin D Deficiency May 2024 February 2025
NCT05382832 Not yet recruiting N/A Botox Vs Spinal Cord Stimulation in the Treatment of Refractory Migraine Clinical Trial August 1, 2022 August 1, 2025
NCT05809375 Not yet recruiting N/A Coping Skills Training in Individuals With Migraine May 2023 July 2023
NCT06161129 Not yet recruiting N/A Filter Lenses for the Prevention of Migraine Attacks March 1, 2024 February 1, 2027
NCT06446804 Not yet recruiting Follow-up of Migraine Patients on Eptinezumab June 1, 2024 December 31, 2024
NCT06224959 Not yet recruiting Migraine and Neuropathic Pain in Osteoarthritis January 31, 2024 January 31, 2025
NCT06414109 Not yet recruiting N/A Mindfulness-Based Intervention for Adolescents With Chronic Migraine June 1, 2024 March 2025
NCT05524493 Not yet recruiting High-field MR Imaging in Migraine and Epilepsy June 1, 2024 June 30, 2024
NCT05334927 Not yet recruiting China HeadAche DIsorders RegiStry August 29, 2022 December 31, 2032
NCT05987592 Not yet recruiting N/A BE WELL With Migraine: Brain Education and WELLness With Migraine June 2024 June 30, 2027
NCT06077448 Not yet recruiting Volumetric MRI Brain in Patients With Migraine October 10, 2023 February 1, 2025
NCT06401642 Not yet recruiting Phase 4 Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications May 2024 March 2027
NCT06428838 Not yet recruiting Phase 3 Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context September 30, 2024 December 30, 2025
NCT06464367 Not yet recruiting Early Phase 1 Mechanistic Studies of Psilocybin in Headache Disorders September 1, 2024 December 31, 2026
NCT06103734 Not yet recruiting Phase 3 A Study to Learn About Zavegepant as a Treatment for Multiple Migraine Attacks in Adult Participants March 31, 2025 February 15, 2027
NCT06237062 Not yet recruiting Migraine Survey in Gulf Region June 30, 2024 March 30, 2025
NCT06440876 Not yet recruiting N/A Music and Imagery for Veterans With Migraine Headache June 15, 2024 August 15, 2025
NCT06203873 Not yet recruiting N/A A Comparison of Biodegradable and Metal Occluders in Patients With PFO and Migraine January 1, 2024 January 2025
NCT05046119 Not yet recruiting Psychological and Biological Markers of Refractory Migraine September 15, 2021 September 15, 2024
NCT05685225 Not yet recruiting Phase 2 Multi-Center Study of Naltrexone-Acetaminophen in Acute Migraine, With an Exploratory Analysis of Co-occurring Anxiety July 1, 2024 July 1, 2026
NCT05675189 Not yet recruiting Exploring Clinical Trial Experiences of Patients With Migraine January 2025 January 2027
NCT06150612 Not yet recruiting N/A Unwinding Anxiety for Migraine: Pilot January 3, 2024 January 1, 2025
NCT05738213 Recruiting N/A Puberty, Sex Hormones and Pain Sensitivity in Adolescents With Migraine January 10, 2023 January 1, 2028
NCT06203678 Recruiting N/A The Effectiveness of Cervical Kinesio Taping in Migraine January 2, 2024 March 1, 2025
NCT05741775 Recruiting Early Phase 1 Physiotherapy Intervention for Migraine Symptoms September 18, 2022 December 2024
NCT05458817 Recruiting N/A Digital-technology Based Interventions on Treatment of Migraine. January 1, 2022 May 31, 2025
NCT05748483 Recruiting Phase 3 Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine October 7, 2023 June 28, 2026
NCT05752396 Recruiting Overlapping Pain Trajectory Study March 1, 2023 July 1, 2028
NCT03832998 Recruiting Phase 3 Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine September 5, 2019 April 4, 2027
NCT04276142 Recruiting N/A Effectiveness of a Dialogue-based Online Intervention Against Migraine June 5, 2023 June 5, 2024
NCT06334237 Recruiting Psychosomatic Factors Influencing the Efficacy of Holistic Care for Migraine April 18, 2024 February 21, 2026
NCT06200480 Recruiting N/A Nurse Intervention Trial April 21, 2023 December 31, 2027
NCT05768828 Recruiting Stimulation-evoked Calcitonin Gene-Related Peptide (CGRP) as Biomarker of Migraine February 20, 2023 July 30, 2023
NCT03836040 Recruiting Phase 3 Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine July 19, 2019 May 5, 2027
NCT06191016 Recruiting N/A Vagal Nerve Stimulation and Pain Frequency, Intensity in Chronic Migraine December 26, 2023 October 31, 2024
NCT03472092 Recruiting Phase 2 Mind and Body Approaches to Pain Reduction in Youth With Migraine October 2, 2018 June 30, 2025
NCT06345326 Recruiting N/A Greater Occipital Nerve Block Versus Pulse Radiofrequency in Migraine January 15, 2023 April 30, 2024
NCT05785988 Recruiting Anti-CGRP Monoclonal Antibody Response After Switching (AMARAS) November 1, 2019 November 10, 2024
NCT06182098 Recruiting N/A Intravenous Fluids in Pediatric Migraine June 27, 2023 June 2025
NCT05281770 Recruiting Monoclonal CGRP Antibodies for Migraine Prevention - a Nationwide Real Life Study October 1, 2022 December 1, 2025
NCT04384367 Recruiting Phase 3 Efficacy and Safety of Rizatriptan-Naproxen (10/550 mg) in the Acute Treatment of Migraine December 30, 2022 January 30, 2025
NCT04396236 Recruiting Phase 3 A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine June 15, 2020 January 31, 2025
NCT04396574 Recruiting Phase 3 A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine June 30, 2020 March 31, 2026
NCT06347497 Recruiting Phase 3 Zonisamide Versus Topiramate in Migraine April 1, 2024 May 1, 2025
NCT05810038 Recruiting Phase 3 A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects. May 15, 2023 December 13, 2025
NCT05454826 Recruiting N/A Investigation of the Effect of Cold Application in Migraine July 1, 2022 August 30, 2022
NCT05827887 Recruiting An Observational Study to Assess Ubrogepant Tablets and Atogepant Tablets to Treat Migraine in Adult Participants June 25, 2023 September 30, 2025
NCT06361446 Recruiting Phase 3 Zonisamide Versus Propranolol in Migraine March 29, 2024 April 20, 2025
NCT06173661 Recruiting Phase 4 Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45 March 1, 2024 July 30, 2026
NCT06372509 Recruiting A Proteomic Analysis for Understanding the Link Between Migraine and Cardiovascular Disease April 3, 2024 October 30, 2025
NCT05232942 Recruiting Monoclonal Antibody Duration of REsponse in MIgraine After Treatment Interruption February 15, 2022 August 15, 2024
NCT04464707 Recruiting Phase 3 A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Patients 6 to 17 Years of Age July 30, 2020 February 22, 2025
NCT05509400 Recruiting Phase 4 Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use October 18, 2022 February 18, 2025
NCT05861427 Recruiting Phase 3 Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episodic Migraine July 12, 2023 May 28, 2025
NCT05226559 Recruiting N/A Effectiveness of Multimodal Physical Therapy in Migraine February 24, 2022 May 2025
NCT05889624 Recruiting N/A Responding With Evidence and Access for Childhood Headaches August 22, 2023 December 31, 2027
NCT05891808 Recruiting miR-155 Expression in Episodic and Chronic Migraine September 22, 2020 January 1, 2024
NCT06170411 Recruiting N/A Post-marketing Clinical Trial of Elexir(Trigeminal Nerve Electrical Stimulator) for the Acute Treatment of Migraine October 27, 2023 August 1, 2024
NCT05893004 Recruiting N/A German Translation and Cross-cultural Adaptation of the Headache Screening Questionnaire (HSQ) Followed by a Test-retest Reliability Study. November 6, 2023 May 1, 2024
NCT05198245 Recruiting Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy December 15, 2021 April 17, 2028
NCT05903027 Recruiting Gepant treAtments: EffectIveNess and tolERability (GAINER) June 15, 2023 June 2024
NCT05903040 Recruiting Ditan Acute tReatments: Effectiveness and Tolerability (DART) June 15, 2023 June 2024
NCT04530110 Recruiting Phase 3 A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents September 16, 2020 March 21, 2026
NCT05907655 Recruiting Study of the Glymphatic System in Migraine April 30, 2023 April 30, 2026
NCT06170281 Recruiting N/A Sequential, Multiple Assignment, Double Randomized Preference, Migraine Behavioral Trial December 15, 2023 December 2025
NCT05517200 Recruiting Pilot Study for a Machine Learning Test for Migraine September 3, 2022 June 2025
NCT05175521 Recruiting N/A Inhaled IAV vs Inhaled Eucalyptus for the Treatment of Nausea With Acute Migraine November 11, 2021 December 23, 2024
NCT04567355 Recruiting Phase 2 Migraine Manager (R01) June 10, 2021 May 31, 2025
NCT06409832 Recruiting RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment March 26, 2024 January 2026
NCT05518123 Recruiting Phase 4 Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications November 7, 2022 February 11, 2025
NCT05164172 Recruiting Phase 3 A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine December 1, 2021 March 1, 2026
NCT05418218 Recruiting International Headache Registry Study July 12, 2021 December 31, 2082
NCT05947123 Recruiting Real-life Study of the Efficacy of Management of Migraine Patients After Failure of 2 Prophylactic Treatments June 1, 2023 June 1, 2025
NCT05158894 Recruiting Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy January 10, 2023 September 29, 2034
NCT05156398 Recruiting Phase 3 Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects February 28, 2022 April 29, 2027
NCT04592952 Recruiting Phase 4 Hypersensitivity to CGRP as a Predictive Biomarker of Migraine Prevention With Erenumab October 8, 2020 August 1, 2025
NCT04607460 Recruiting N/A EMG Biofeedback Treatment for Chronic Low Back Pain, Cancer Pain and Migraines December 3, 2020 December 30, 2023
NCT06409845 Recruiting Effectiveness and Tolerability of Eptinezumab March 26, 2024 April 2026
NCT06414044 Recruiting Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients May 9, 2024 April 2026
NCT04674020 Recruiting Phase 4 Registry for Migraine - Structural and Functional MRI Before and After Erenumab Treatment October 22, 2020 July 22, 2025
NCT04696458 Recruiting N/A Effects of a Multispecies Probiotic on Migraine April 15, 2021 April 1, 2024
NCT04702971 Recruiting Phase 4 Decoding Pain Sensitivity in Migraine With Multimodal Brainstem-based Neurosignature February 26, 2021 December 2025
NCT04715685 Recruiting N/A Mind Body Balance for Pediatric Migraine March 9, 2021 May 31, 2025
NCT04726592 Recruiting Phase 3 Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room July 8, 2021 December 1, 2024
NCT05989048 Recruiting Phase 3 A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults November 29, 2023 July 19, 2025
NCT06158737 Recruiting Phase 1 A Clinical Trial Evaluated the Safety and Tolerability, Pharmacokinetic and Pharmacodynamics Profile, and Immunogenicity of a Single Dose of JS010 Injection in Healthy Subjects May 9, 2023 September 21, 2024
NCT06016465 Recruiting Early Phase 1 Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs? September 15, 2023 September 10, 2024
NCT06029153 Recruiting N/A Efficacy and Safety of Middle Meningeal Artery Embolization for Treatment of Intractable Migraine June 15, 2023 August 31, 2024
NCT05125302 Recruiting Phase 3 Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) January 13, 2022 May 5, 2026
NCT05415020 Recruiting N/A Determining the Utility of a Behavioral Intervention in Chronic Migraine June 29, 2022 February 3, 2025
NCT05046613 Recruiting Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant November 3, 2021 April 30, 2034
NCT02903680 Recruiting Phase 1 RCT of IV Dexamethasone to Prevent Relapse in the Treatment of Migraine in a Paediatric ED May 2014 June 2024
NCT06459635 Recruiting Migraine Attack Pain Phase Prediction Study October 9, 2023 December 2025
NCT05042037 Recruiting N/A Probiotics as Adjunctive Migraine Prophylaxis October 1, 2022 December 1, 2024
NCT06150781 Recruiting Aimovig Pregnancy Exposure Registry January 27, 2021 October 28, 2027
NCT06085144 Recruiting Emgality for Migraine in Breastmilk December 2023 April 2026
NCT04921384 Recruiting Phase 3 Eptinezumab as Preventive Treatment of Migraine in Adults With Migraine May 29, 2021 March 11, 2025
NCT04925414 Recruiting Phase 4 Migraine and High Flow Oxygenotherapy at the Emergency Department (MiOx) October 1, 2023 October 2024
NCT04930887 Recruiting Phase 2 Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain February 1, 2023 June 2030
NCT05411978 Recruiting Phase 4 Safety and Efficacy of Oral Idebenone for Preventive Treatment of Migraine in Adult Migraine Patients May 9, 2022 June 20, 2024
NCT04939922 Recruiting China Headache Registry Study June 12, 2017 December 12, 2050
NCT05537818 Recruiting N/A AVPI Migraine Study June 30, 2022 January 31, 2024
NCT06089356 Recruiting Phase 4 Zolmitriptane as Prophylaxis for Chilhood Migraine January 1, 2023 January 1, 2024
NCT04946734 Recruiting Phase 3 Effectivity and Safety of PFO Closure vs Medicine in Alleviating Migraine August 12, 2021 July 1, 2025
NCT00071786 Recruiting Family Study of Affective and Anxiety Spectrum Disorders May 21, 2004
NCT06417775 Recruiting Phase 3 Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine May 23, 2024 September 8, 2027
NCT05546320 Recruiting Phase 4 Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale October 15, 2022 June 1, 2025
NCT06241313 Recruiting Phase 3 Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine March 25, 2024 November 30, 2025
NCT03694626 Recruiting N/A Objectively Diagnose and Monitor Treatment of Light Sensitivity July 11, 2019 January 1, 2028
NCT05550207 Recruiting Phase 3 Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE) August 31, 2022 December 2024
NCT06267664 Recruiting Real-world Effectiveness and Tolerability of Triptans-Ditans-Gepants (TRIDIGEP) December 4, 2023 December 1, 2024
NCT03982316 Recruiting N/A Telehealth Behavioral Migraine Management September 15, 2020 September 2024
NCT05561660 Recruiting Phase 4 COMParison of the EffecT of dEvice Closure in Alleviating Migraine With PFO (COMPETE-2) October 1, 2022 October 1, 2025
NCT06459648 Recruiting Study for Prevent Chronification Migraine Through Prediction of Response to Treatment With Anti-CGRP Antibodies April 26, 2023 December 2025
NCT04007874 Recruiting Phase 3 Oral Contraceptive Pill Compared With Vitamin E in Women With Migraine September 10, 2019 December 2024
NCT03592329 Recruiting N/A Vagus Nerve Stimulation and Stress Reduction Training for Migraine August 20, 2019 July 31, 2024
NCT05576467 Recruiting N/A Treatment for Migraine and Mood RCT July 2024 July 2025
NCT05468801 Recruiting N/A Efficacy of Individualized Homeopathic Remedies on Migraine: a Randomized, Triple-blind, Placebo Controlled Study. March 1, 2019 November 1, 2023
NCT06221267 Recruiting A Registry Study on Rimegepant for the Treatment of Migraine Participants in Guangdong-Hong Kong-Macao Greater Bay Area January 26, 2024 June 30, 2024
NCT05641363 Recruiting Phase 3 Comparison of Ketorolac at Three Doses in Children With Acute Pain June 1, 2023 February 2025
NCT05646160 Recruiting N/A Effects of MTRPs Therapy in Migraine. January 15, 2018 March 2, 2023
NCT05653986 Recruiting An Observational Study to Assess Change in Disease Activity When Ubrogepant Tablets Are Combined With Atogepant Tablets to Treat Migraine in Adult Participants December 18, 2022 April 30, 2024
NCT05654012 Recruiting N/A Migraine in Adolescents June 1, 2023 March 15, 2030
NCT06323928 Recruiting Phase 2 A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments April 1, 2024 September 30, 2025
NCT06212869 Recruiting N/A Green Light and Transcranial Direct Current Stimulation in Migraine Patients January 18, 2024 October 31, 2024
NCT05669703 Recruiting NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder November 3, 2023 July 31, 2026
NCT05452239 Recruiting Phase 4 A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache July 1, 2022 March 11, 2025
NCT05704335 Recruiting InfluenCEF Study: Study on the Headache Associated With Influenza Infection December 20, 2022 November 30, 2024
NCT05709106 Recruiting A Prospective Real World Study of Rimegepant in the Treatment of Migraine February 8, 2023 December 30, 2025
NCT05718310 Recruiting N/A Habituation of the Nociceptive Blink Reflex in Experimentally Induced Migraine Attack November 1, 2022 December 2024
NCT06051604 Recruiting N/A Mi-Helper Transnasal Cooling for Acute Treatment of Migraine November 15, 2023 March 2025
NCT06072287 Recruiting The Living With a Long-Term Condition Study June 28, 2023 January 10, 2024
NCT06077812 Recruiting N/A NYU Langone Health Headache Center Learning Migraine Self-Management Techniques Study November 27, 2023 December 2025
NCT06077838 Recruiting N/A RELAXaHEAD for Headache Patients (Phase III) November 6, 2023 December 2028
NCT06033937 Recruiting COMPETE Cohort Study January 1, 2022 December 1, 2025
NCT05427630 Suspended Phase 2 Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment February 15, 2023 June 1, 2024
NCT00529945 Suspended N/A PFx Closure System in Subjects With Cryptogenic Stroke, TIA, Migraine or Decompression Illness August 2007 December 2007
NCT04069572 Suspended N/A Vibratory Stimulation for the Treatment of Chronic Pain September 2024 December 2025
NCT02582996 Suspended Phase 3 Cefalium® Compared to Tylenol® in the Treatment of Migraine Attacks April 2020 June 2021
NCT01488110 Terminated N/A Investigation of Efficacy and Outcome of a New Medical Device for Treatment of Migraine January 2012
NCT00747812 Terminated Phase 2 Study of Occipital Nerve Stimulation for Drug Refractory Migraine May 2006 May 2012
NCT00797667 Terminated Phase 2 MK0974 (Telcagepant) for Migraine Prophylaxis in Patients With Episodic Migraine (0974-049) November 12, 2008 May 20, 2009
NCT05492695 Terminated Phase 4 Tandem OnabotulinumtoxinA Galcanezumab Emerging Therapeutic Headache Elimination Research Study October 1, 2022 September 28, 2023
NCT00820105 Terminated Phase 2 ADX10059 Migraine Prevention Study December 2008
NCT03912337 Terminated Phase 4 Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine December 4, 2019 July 28, 2021
NCT05596058 Terminated N/A Non-pharmacological Treatments in Migraine. June 1, 2022 November 1, 2023
NCT01253915 Terminated Phase 2 The Effect of Nasal Carbon Dioxide in the Treatment of Moderate to Severe Migraine January 2012 June 2013
NCT01395264 Terminated Saccadometry in Primary Headache Syndromes August 2011 October 27, 2017
NCT01421277 Terminated Study of Treatment Used for Migraine Headaches (MK-0974-076) May 19, 2011 March 23, 2012
NCT00739024 Terminated Phase 2 A Study of a Melatonin Receptor Agonist to Prevent Migraine April 2008 September 2010
NCT01581281 Terminated Phase 3 The Childhood and Adolescent Migraine Prevention Study June 2012 January 2016
NCT01803984 Terminated MIBRAIN - Migraine and the Brain: Consequences, Causes, and Vascular Interaction March 22, 2013 December 3, 2014
NCT01855672 Terminated Phase 1 Occipital Nerve Stimulation in the Treatment of Migraine April 2013 July 2013
NCT01857557 Terminated N/A Evaluation of an Aerobic Exercise Program in Migraine Management August 2012 August 6, 2020
NCT01859052 Terminated N/A Diet and Migraine Study July 2012 May 2015
NCT01981499 Terminated Phase 1 A Study of the Safety, Tolerability, Pharmacokinetics, And Effects On Histamine-Induced Wheal Of PF-05180999 In Healthy Adults January 2014 April 2014
NCT00203307 Terminated N/A A Research Study Examining the Use of Olanzapine for the Prevention of Migraine May 2004 June 2006
NCT02132429 Terminated Phase 1 Phase I, Double-Blind,Placebo, MAD Study to Evaluate the Safety, Tolerability, PK, and PD of AMG 333 in Healthy Subjects and Migraine Subjects May 2014 December 2014
NCT00505570 Terminated Phase 2 PRIMA PFO Migraine Trial May 2006 February 2013
NCT04804033 Terminated Phase 2/Phase 3 A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention March 26, 2021 March 21, 2024
NCT00369499 Terminated N/A STOP PAIN: Septal Closure of PFO - Does it Prevent Migraine? March 2007 June 2009
NCT04936061 Terminated N/A Transnasal Cooling for Migraine October 14, 2021 September 30, 2022
NCT02630719 Terminated N/A Timolol Eye Drops in the Treatment of Acute Migraine Headache January 2016 August 1, 2017
NCT02964741 Terminated N/A Investigation and Modulation of the Mu-Opioid Mechanisms in Migraine (in Vivo) February 22, 2017 August 1, 2021
NCT00329732 Terminated N/A Research Study of Greater Occipital Nerve Block As A Treatment For Prolonged Migraine Attacks March 2006 April 2006
NCT03022838 Terminated Phase 2/Phase 3 The Effects of Caffeine Withdrawal on Migraine February 28, 2017 July 22, 2019
NCT03150797 Terminated Phase 2 Melatonin for Adolescent Migraine Prevention Study August 2, 2017 December 1, 2019
NCT03185559 Terminated N/A A Randomized, Double-blind Clinical Investigation to Evaluate the Use of the Relievion™ Device in Treating Migraine. July 23, 2017 January 9, 2018
NCT03263897 Terminated N/A Feasibility of Using a Mobile Device Controlled Micro-pressure Pulse Insufflator for Acute Migraine Relief August 21, 2017 December 31, 2020
NCT00298805 Terminated A Quality of Life Study in Patients With Migraines January 2006 April 2013
NCT00291395 Terminated Phase 1 PGI2 Induced Headache and Cerebral Haemodynamics in Healthy Volunteers September 2005
NCT03410628 Terminated N/A Non-invasive Neurostimulation for the Relief of Migraine July 2011 December 2011
NCT05284019 Terminated Phase 4 Real World Effectiveness of Eptinezumab in Participants With Migraine March 4, 2022 April 14, 2023
NCT03660618 Terminated N/A LSFG-SKIN, Laser Speckle Flowgraphy May 23, 2017 March 2, 2019
NCT02854930 Unknown status Near Death Experience (NDE) and Migraine January 2017 March 2018
NCT04842474 Unknown status N/A Effectiveness of Gaze Stability Exercises on Balance and Activities of Daily Living Among Patients Suffering Vertigo With Vestibular Neuritis in Saudi Arabia February 7, 2021 January 2022
NCT02532023 Unknown status Phase 4 The Combined Effects of omega3 Fatty Acids and Curcumin Supplementation on Inflammatory and Endothelial Factors in Migraine Patients September 2015 February 2017
NCT02938182 Unknown status Phase 4 Migraine Prophylaxis With Clopidogrel Trial October 2016 October 2023
NCT03507400 Unknown status N/A Introvision for Migraine and Headaches September 20, 2017 May 2020
NCT04305522 Unknown status N/A Probiotics for the Prophylaxis of Migraine March 2, 2020 May 2, 2021
NCT04219345 Unknown status N/A Transcranial Direct Current Stimulation Associated With Mindfulness in Chronic Migraine March 30, 2020 June 30, 2020
NCT04211454 Unknown status A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Migraine Headaches March 2, 2020 July 2023
NCT01228552 Unknown status Phase 3 The Efficacy and Safety of Intra-oral Topical Ketoprofen for the Treatment of Acute Migraine December 2011 January 2012
NCT04104399 Unknown status Phase 1 Single Ascending Dose Study to Investigate the Safety and Pharmacokinetics of XC101-D13H in Healthy Adult Subjects October 8, 2019 March 30, 2022
NCT03576820 Unknown status Phase 3 Intranasal Lidocaine to Treat Pediatric Migraine in the Emergency Department October 15, 2018 December 2022
NCT01050972 Unknown status Phase 3 Effectiveness of a Cognitive and Physical Intervention to Reduce Head and Muscle Pain in a Large Population June 2009 November 2011
NCT00285402 Unknown status Phase 2 Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine May 2007 June 2008
NCT01010711 Unknown status N/A Influence of a Dietary Supplement as Treatment of Migraine in Children and Adolescents November 2009 April 2011
NCT02645370 Unknown status Phase 1 Efficacy and Safety of Danzhen February 2016
NCT04984720 Unknown status N/A Efficacy of Smartphone Based Digital Application in Improving Headache Related Parameters in Patients With Migraine July 25, 2021 January 31, 2023
NCT02784847 Unknown status Early Phase 1 A Pilot Trial of Triheptanoin for the Preventive Treatment of Migraine June 2016 November 2016
NCT04904458 Unknown status N/A Enfacement Illusion and Chronic Migraine Pain April 30, 2021 March 30, 2024
NCT04904328 Unknown status N/A A Proof of Concept Alleviating the Symptoms of Photosensitive Migraine. June 30, 2021 April 4, 2022
NCT02820974 Unknown status The Functional Magnetic Resonance Imaging Study on the Processing of Acute Pain and Cognition Among Perimenopause Women November 2016 December 2019
NCT04890691 Unknown status N/A The Effect of Bright Light Therapy on Migraine With Sleep Disturbance June 15, 2021 June 14, 2023
NCT02838537 Unknown status TRiptan Use and Serious Vascular Events in Elderly Over 65 Years November 2015 May 2017
NCT04859374 Unknown status N/A Chronic Pain and Conditioned Pain Modulation After on Line-behavioral Approach September 2021 May 2022
NCT02583581 Unknown status N/A Evaluation of Use of Brain Activity Monitoring for Prediction of Migraine Attacks October 2015 February 2018
NCT02954276 Unknown status Phase 1 Comparative Bioavailability Study of Omexa Sumatriptan vs. Imitrex® in Healthy Volunteers March 2016 December 2016
NCT04803513 Unknown status Observational Study on the Efficacy, Safety, and Tolerability of GAlcanezumab in Real Life Migraine Patients in ITaly November 1, 2019 August 31, 2022
NCT00363571 Unknown status N/A The Effect of Glyceryl Trinitate and Diamox on Cerebral Haemodynamics. August 2006 May 2007
NCT00286923 Unknown status Does Topiramate Adjust the Excitability of the Brain in Migraine Sufferers? February 2006 August 2006
NCT05086562 Unknown status Prevalence of Chronic Abdominal Pain in Migraneurs September 1, 2021 December 30, 2023
NCT00060619 Unknown status N/A Migraine and Recurrent Abdominal Pain in Children May 1999 June 2004
NCT00969995 Unknown status Identification of Inflammatory Markers in Migraine Patients September 2009 December 2011
NCT03900611 Unknown status N/A Peripheral Electrical Stimulation for Migraine Prevention February 1, 2021 December 31, 2022
NCT05101837 Unknown status N/A Feasibility and Effectiveness of a Specific App to Delivery Mindfulness Sessions October 2021 April 2022
NCT03066544 Unknown status Phase 1/Phase 2 Status Migrainosus - Differentiating Between Responders and Non-responders November 30, 2016 June 30, 2020
NCT00316979 Unknown status N/A Efficacy of rTMS in the Treatment of Patients With Migraine April 2006
NCT02458326 Unknown status Phase 1 Aerobic Training Effect on the Improvement of Pain Perception in Patients With Fibromyalgia and Migraine April 2015 September 2015
NCT03083860 Unknown status N/A Evaluation of Migraine Management Mobile App Combined With Electrophysiological Measurements for Identification of Migraine Attack Risk and Beneficial Preventive Actions. September 2017 December 2018
NCT00155129 Unknown status The Role of CGRPand Nociceptin in Migraine January 2005 June 2005
NCT02342262 Unknown status N/A The Effect of Probiotics on the Frequency and Intensity of Migraine Attacks and Intestinal Permeability August 2014 October 2015
NCT03155360 Unknown status Infants Colics : Towards a Migrainous Origin ? May 18, 2017 November 1, 2017
NCT04603976 Unknown status Phase 4 Registry for Migraine - Clinical Core September 25, 2020 October 2022
NCT04580641 Unknown status Validation of a Questionnaire for Allodynia in Migraine. October 1, 2020 September 2021
NCT02196532 Unknown status Retinal Nerve Fiber Layer Thickness Changes in Migraine: A Meta-Analysis of Case-control Studies July 2014 July 2015
NCT05161871 Unknown status N/A Transcranial Direct Current Stimulation Plus Monoclonal Antibodies Acting on the CGRP Pathway for Migraine May 16, 2022 April 16, 2023
NCT04575623 Unknown status Auditory Functions in Patients With Migraine October 1, 2021 October 1, 2023
NCT00510172 Unknown status N/A Migraine Inducing Effects and Changes in Brain Haemodynamics of PGI2 December 2006 September 2007
NCT04547179 Unknown status N/A Medicinal vs. Orthotic Comparison for Migraine Prevention: A Double-Blind Study February 1, 2021 December 1, 2021
NCT03221569 Unknown status Phase 4 Ketamine v. Ketorolac for Management of Generalized Tension Type Headache February 1, 2016 February 1, 2020
NCT04503083 Unknown status BIOmarkers of MIGraine: a Proof of Concept Study Based on the Stratification of Responders to CGRP Monoclonal Antibodies January 15, 2021 March 1, 2023
NCT01905748 Unknown status N/A Acute Phase Reactions and Thrombophilia in Pediatric Patients With Migraine August 2011 December 31, 2020
NCT05202171 Unknown status N/A The Effects of Cervical Stabilization Exercise Training With Telerehabilitation in Individuals With Migraine February 2022 June 2023
NCT03727672 Unknown status Salivary Inflammatory Markers in Tension Type Headache and Migraine January 1, 2016 December 30, 2020
NCT00283738 Unknown status Phase 2/Phase 3 MIST II PFO-Migraine Trial With BioSTAR® Bioabsorbable Septal Repair Implant February 2006 March 2008
NCT01886274 Unknown status Phase 2 Does tDCS is Effective in the Prophylactic Treatment of Migraine October 2012 October 2014
NCT00204074 Unknown status Phase 2/Phase 3 Treatment of Menstrual Migraine With Sequential, Transdermal, 17-Beta-Estradiol. A Double-Blind, Randomised, Cross-Over Trial. October 2001 July 2005
NCT05235776 Unknown status New-onset Severe Headache After Covid-19 Vaccine January 1, 2022 December 31, 2023
NCT04452929 Unknown status N/A The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients July 22, 2020 July 2022
NCT04360148 Unknown status N/A Th Effect of Ketogenic Metabolic Nutritional Pattern on High-frequency Episodic Migraine (EMIKETO) February 6, 2020 May 30, 2021
NCT04356079 Unknown status Familial and Environmental Factors Behind Migraine April 2020 August 2020
NCT03481400 Unknown status N/A CGRP-induced Migraine Attacks in Patients Who Have Tried Anti-CGRP Monoclonal Antibody Treatment July 2016 September 2019
NCT03487978 Unknown status Longitudinal Changes of Brain Functional Connectivity in Migraine July 24, 2017 February 28, 2023
NCT03494673 Unknown status Prediction of WMH in Migraine Using a BOLD-CVR Map July 13, 2018 February 28, 2020
NCT01618201 Unknown status Inflammatory Markers Identification in Migraine Patients June 2012 June 2014
NCT02945839 Withdrawn Phase 4 Improving Health Outcomes of Migraine Patients Who Present to the Emergency Department December 28, 2016 December 2019
NCT03159000 Withdrawn Phase 4 A Research Study of Greater Occipital Nerve Block as a Treatment for Acute Migraine Attacks May 1, 2017 June 30, 2018
NCT01534806 Withdrawn Phase 4 Prochlorperazine Versus Prochlorperazine & Ketorolac in Treatment of Pediatric Migraine in the Emergency Department January 2012
NCT04008303 Withdrawn Outcomes of Migraine Surgery May 2020 June 1, 2020
NCT04334408 Withdrawn Phase 2 Safety and Efficacy of Fremanezumab for Migraine in Adult CADASIL December 2021 December 2024
NCT00259636 Withdrawn Phase 4 Zonisamide for Fibromyalgia & Migraine August 2004 January 2008
NCT01390324 Withdrawn Phase 3 Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine December 2011 March 2012
NCT00888680 Withdrawn Phase 2 Double-blind, Placebo-controlled Study of BGC20-1531 in Migraine
NCT01726920 Withdrawn Phase 3 Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine. July 2014
NCT00777218 Withdrawn N/A Cognitive Side Effects of Commonly Prescribed Medications in Pediatric Migraine August 2007 July 2011
NCT00557544 Withdrawn Phase 3 Trial on Metoclopramide and Ketoprofen in Acute Migraine of Childhood June 2009 June 2010
NCT01981486 Withdrawn Phase 1 A Study Of The Safety, Tolerability, And Pharmacokinetics Of Multiple Doses Of PF-05180999 In Healthy Adults June 2014 January 2015
NCT02643719 Withdrawn N/A Migraine Treatment in ED December 2015 October 2017
NCT00732108 Withdrawn N/A Is Topiramate Effective in Treating Dizziness in Patient's With Migraine-Associated Dizziness November 2008
NCT03280342 Withdrawn Phase 2 Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With Migraine October 30, 2017 September 13, 2018
NCT03787238 Withdrawn N/A A Randomized, Multicenter, Study for the prEvention and Acute Treatment of Migraine (REAL) May 15, 2019 October 1, 2020
NCT04114630 Withdrawn Phase 3 Study of Quality of Life in Subjects With Chronic or High-frequency Episodic Migraine and Associated Comorbidities Treated With Erenumab October 30, 2019 January 7, 2022
NCT05523310 Withdrawn Observational Study to Assess Migraine Prediction Tool May 1, 2023 November 15, 2023
NCT00640965 Withdrawn Phase 2 DP-VPA for Migraine Prophylaxis, a Pilot Efficacy Study July 2008 August 2009
NCT01653522 Withdrawn N/A The Impact of Triptan and Doxycycline on Neuroinflammatory Biomarkers in Acute Migraine July 2012 July 2014
Disase is a (Disease Ontology)
DOID:936
Cross Reference ID (Disease Ontology)
ICD10CM:G43
Cross Reference ID (Disease Ontology)
ICD9CM:346
Cross Reference ID (Disease Ontology)
MESH:D008881
Cross Reference ID (Disease Ontology)
MIM:157300
Cross Reference ID (Disease Ontology)
NCI:C89715
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:155046006
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:193036004
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0042331
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0149931
Exact Synonym (Disease Ontology)
migraine disorder
Exact Synonym (Disease Ontology)
migraine variant
Exact Synonym (Disease Ontology)
migraine with or without aura
HPO alt_id (Human Phenotype Ontology)
HP:0007194
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0002076
MedGen concept unique identifier (MedGen Concept name)
C0149931
MedGen unique identifier (MedGen Concept name)
57451
ICD10 preferred id (Insert disease from ICD10)
D0005366
ICD10 class code (Insert disease from ICD10)
G43